These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34007848)

  • 1. Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms.
    Wu M; Xu H; Liu J; Tan X; Wan S; Guo M; Long Y; Xu Y
    J Diabetes Res; 2021; 2021():6673525. PubMed ID: 34007848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity.
    Luo T; Nocon A; Fry J; Sherban A; Rui X; Jiang B; Xu XJ; Han J; Yan Y; Yang Q; Li Q; Zang M
    Diabetes; 2016 Aug; 65(8):2295-310. PubMed ID: 27207538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.
    Sato Y; Qiu J; Hirose T; Miura T; Sato Y; Kohzuki M; Ito O
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G464-G473. PubMed ID: 33439105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures.
    Łabuzek K; Liber S; Gabryel B; Okopień B
    Pharmacol Rep; 2010; 62(5):827-48. PubMed ID: 21098866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist.
    Buler M; Aatsinki SM; Skoumal R; Komka Z; Tóth M; Kerkelä R; Georgiadi A; Kersten S; Hakkola J
    J Biol Chem; 2012 Jan; 287(3):1847-60. PubMed ID: 22117073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and application of metformin in kidney diseases: An update.
    Song A; Zhang C; Meng X
    Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
    Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation.
    Di Fusco D; Dinallo V; Monteleone I; Laudisi F; Marafini I; Franzè E; Di Grazia A; Dwairi R; Colantoni A; Ortenzi A; Stolfi C; Monteleone G
    Clin Sci (Lond); 2018 Jun; 132(11):1155-1168. PubMed ID: 29540537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of AMP-activated protein kinase inhibits ER stress and renal fibrosis.
    Kim H; Moon SY; Kim JS; Baek CH; Kim M; Min JY; Lee SK
    Am J Physiol Renal Physiol; 2015 Feb; 308(3):F226-36. PubMed ID: 25428127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner.
    Zhang F; Dey D; Bränström R; Forsberg L; Lu M; Zhang Q; Sjöholm A
    Am J Physiol Cell Physiol; 2009 Feb; 296(2):C346-54. PubMed ID: 19052259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock.
    Matsiukevich D; Piraino G; Lahni P; Hake PW; Wolfe V; O'Connor M; James J; Zingarelli B
    Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt B):2680-2691. PubMed ID: 28579457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective Effects of Metformin.
    Driver C; Bamitale KDS; Kazi A; Olla M; Nyane NA; Owira PMO
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):121-127. PubMed ID: 29738369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation.
    Lin JT; Chen HM; Chiu CH; Liang YJ
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1253-65. PubMed ID: 24857754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.
    Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Nimal S; Longnus SL; Van Obberghen E; Hainault I; Foufelle F; Kahn R; Braun U; Leitges M; Farese RV
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E179-92. PubMed ID: 19887597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
    Daskalopoulos EP; Dufeys C; Bertrand L; Beauloye C; Horman S
    J Mol Cell Cardiol; 2016 Feb; 91():188-200. PubMed ID: 26772531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.